BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,546 | +2.1% | 33,128 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $229,659 | +27.6% | 32,622 | +128.4% | 0.00% | 0.0% |
| Q3 2022 | $180,000 | -42.9% | 14,285 | -53.8% | 0.00% | 0.0% |
| Q1 2021 | $315,000 | -76.3% | 30,950 | -82.6% | 0.00% | -83.3% |
| Q4 2020 | $1,329,000 | +198.7% | 178,325 | +37.7% | 0.01% | +200.0% |
| Q3 2020 | $445,000 | +12.7% | 129,470 | +56.1% | 0.00% | 0.0% |
| Q2 2020 | $395,000 | +66.0% | 82,955 | -30.4% | 0.00% | 0.0% |
| Q1 2020 | $238,000 | -22.5% | 119,180 | +33.8% | 0.00% | 0.0% |
| Q4 2019 | $307,000 | +132.6% | 89,050 | +253.8% | 0.00% | +100.0% |
| Q3 2017 | $132,000 | +13.8% | 25,170 | +95.7% | 0.00% | 0.0% |
| Q1 2015 | $116,000 | – | 12,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |